An important effect of loss of PRLR expression in HR + MCF7 breast cancer cells were the promotion of luminal-to-basal conversion as measured by the loss of expression of the luminal markers CK18 and ER and the gain in stem cell marker CD44 expression. Here, PRLR is linked to breast carcinoma.